Ultromics offers EchoGo®, an AI-powered diagnostic tool that analyzes routine echocardiograms to identify heart failure with preserved ejection fraction (HFpEF) and cardiac amyloidosis, providing actionable insights within 20 minutes. This technology addresses the challenge of underdiagnosed cardiac conditions by delivering clinically validated assessments with high sensitivity and specificity, streamlining the diagnostic process for healthcare providers.
Funding
$71.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
TBFounders
Product
Problem
Heart failure with preserved ejection fraction (HFpEF) and cardiac amyloidosis are often underdiagnosed due to the complexity of these conditions and limitations in traditional diagnostic methods. Delayed or inaccurate diagnoses can lead to poorer patient outcomes and increased healthcare costs.
Solution
Ultromics offers EchoGo®, an AI-powered platform that analyzes routine echocardiograms to improve the detection of HFpEF and cardiac amyloidosis. The platform uses machine learning algorithms trained on extensive outcome data to identify subtle patterns indicative of these conditions. EchoGo® integrates into existing clinical workflows, providing automated reports with clinically validated assessments in under 20 minutes. By improving diagnostic accuracy and speed, EchoGo® enables healthcare providers to make more informed decisions and deliver timely treatment to patients.
Target Audience
The primary target audience includes cardiologists, echocardiographers, and other healthcare professionals involved in the diagnosis and management of heart failure and cardiac amyloidosis, as well as hospitals and clinics seeking to improve diagnostic accuracy and efficiency.
Features
- AI-powered analysis of echocardiograms for HFpEF and cardiac amyloidosis detection
- Algorithms trained on over 10 years of outcome data from global partnerships
- Automated report generation in under 20 minutes
- Seamless integration with existing DICOM workflows and IT infrastructure
- Secure cloud VPN connection with anonymized data
- Reimbursable for both inpatient and outpatient settings (specific codes and amounts vary)
- Minimal training required for staff onboarding